Clinical Trial Update: Infliximab and Methotrexate in Ankylosing Spondylitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating infliximab with methotrexate for ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Remicade (infliximab)
• Trexall (Methotrexate)

Snippet

Sponsor: University Hospital, Tours | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED